MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics December 23, 2025
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics December 15, 2025
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 October 29, 2025
